Drug Research

Researchers discovered that by turning off the function of two genes, stomach tumours can become resistant to ATR inhibitors. As a result, genetic screening tests may one day be used to identify patients with cancers that are most likely...

The Centers for Disease Control and Prevention on October 19 advised adults in the United States to take Covid boosters from Novavax, even those who had received their primary round of doses from Pfizer, Moderna, or Johnson & Johnson. Adults 18...

A total of $38 million has been granted by the US Food and Drug Administration (FDA) in the form of 19 new grants and two new contracts to support the forthcoming four years of clinical trial trials and regulatory...

Remdesivir from Gilead Sciences and MBP134, an experimental Ebola antibody drug from Mapp Biopharmaceutical Inc., were sent by the United States last week, ending October 15th, to Uganda to help protect healthcare workers reacting to an outbreak that has...

Amgen's market forecast for 2022 explains how competition has led to healthcare cost savings and predicts that a sizable proportion of biologics will compete with biosimilars in five to ten years. The statistics showed that adoption in the US has...

Peter Marks, a top official at the Food and Drug Administration, is not tasked with determining if the expense of the medicines his teams are reviewing is justifiable. However, he is concerned that if businesses can't figure out how...

On October 12, 2022, Moderna revealed that Merck, also known as MSD outside of the US and Canada, had chosen to use its $250 million alternative to jointly create and distribute the PCV mRNA-4157/V940. The vaccine is now being...